ABBV vs MA: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Mastercard Incorporated — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-15.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Mastercard Incorporated · Financial Services
$574.42
+25.0% upside to fair value
Med Conviction
Grade A-
High Quality
QuantHub Verdict
MA has more upside to fair value
(+25.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
MA |
| Current Price |
$261.70 |
$574.42 |
| Fair Value Estimate |
$259.04 |
$718.00 |
| Upside to Fair Value |
-1.0%
|
+25.0%
|
| Market Cap |
$462.4B |
$503.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
23.4x
|
| Price / Sales |
7.2x
|
14.4x
|
| Price / FCF |
23.6x
|
30.8x
|
| Revenue Growth YoY |
+10.2%
|
+14.1%
|
| Gross Margin |
71.5%
|
100%
|
| Operating Margin |
29.3%
|
59.8%
|
| Return on Equity |
-136.5%
|
232.5%
|
| Dividend Yield |
2.61% |
0.59% |
| FCF Yield |
4.25%
|
3.25%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Mastercard operates a global payments network that connects issuers, acquirers, merchants and consumers across more than 200 countries and territories, monetizing payment volumes, cross-border activity and higher-growth value-added services. Business quality is high because its two-sided network, trusted authorization-clearing-settlement infrastructure, brand, security capabilities and broad acce…
Accumulation Zones
| Metric |
ABBV |
MA |
| Zone Low |
$194.28 |
$538.50 |
| Zone High |
$220.18 |
$610.30 |
| In Buy Zone? |
No
|
Yes
|